Hállux Rígidus: prospective study of joint replacement with hemiarthroplasty

Abstracts

OBJECTIVE: To report the results of medium-term follow-up after deploying arthrosurface-Hemicap® in patients with diagnosis of hállux rígidus (HR). METHOD: Eleven patients underwent partial arthroplasty of the first metatarsal-phalangeal joint. six women and five men with an average age 51.9 years (46 to 58 years) and average postoperative follow-up of 3.73 years (3-4 years); were classified through the Kravitz system and evaluated by the american orthopaedic foot and ankle society (aofas) scales for hallux, visual analogical scale (vas) - analog functional pain - and motion range in the first metatarsal joint in preoperative, postoperative after six months and present post-operative. RESULTS: The results show significant improvement of the three analyzed parameters, both for overall analysis and for pre and post-operative comparisons individually. the comparative analysis of each variable in the six months and the current postoperative periods do not show statistically significant differences, indicating maintenance of parameters during this interval. CONCLUSION: Hemiarthroplasty of first metatarsophalangeal joint is a reproducible and safe option for the surgical treatment of hállux rígidus ii and iii, with significant improvement of the evaluated parameters for the studied population. Level of Evidence IV, Case Series.

Hallux rigidus; osteoarthrosis; Hemiarthroplasty

OBJETIVO: Relatar os resultados com médio prazo de seguimento após a implantação de Arthrosurface-HemiCap® em pacientes com diagnóstico de hállux rígidus (HR). MÉTODO: Onze pacientes foram submetidos à artroplastia parcial da primeira metatarso-falangeana. Seis mulheres e cinco homens com idade média de 51,9 anos (46 a 58 anos) e média de seguimento pós-operatório de 3,73 anos (3-4 anos); foram classificados através do sistema de Kravitz e avaliados pelas escalas da american orthopaedic foot and ankle society (AOFAS) para hállux, visual analog scale (VAS) - analógico funcional de dor - e pela amplitude de movimento da primeira articulação metatarsofalangeana no periodo pré-operatório, pós-operatório de seis meses e pós-operatório atual. RESULTADOS: Os resultados revelam melhora significativa dos três parâmetros analisados no estudo, tanto para análise global como para comparações pré e pós-operatórias individuais. A análise comparativa de cada variável nos períodos pós-operatórios de seis meses e atual não mostram diferença estatística o que indica manutenção dos parâmetros durante esse intervalo. CONCLUSÃO: A hemiartroplastia da primeira metatarsofalangeana é opção reprodutível e segura para o tratamento cirúrgico do hállux rígidus II e III, com significativa melhora dos parâmetros avaliados para a população estudada. Nível de Evidência IV, Série de casos.

Hállux rígidus; Osteoartrose; Hemiartroplastia

ORIGINAL ARTICLE

Hállux Rígidus: prospective study of joint replacement with hemiarthroplasty

Alexandre Leme Godoy dos Santos; Fernando Aires Duarte; Carlos Augusto Itiu Seito; Rafael Trevisan Ortiz; Marcos Hideyo Sakaki; Túlio Diniz Fernandes

Institute of Orthopedics and Traumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo – FMUSP, São Paulo, SP, Brazil

Mailing address

ABSTRACT

OBJECTIVE: To report the results of medium-term follow-up after deploying Arthrosurface-HemiCap^® in patients with diagnosis of Hállux Rigidus (HR).

METHOD: Eleven patients underwent partial Arthroplasty of the first metatarsal-phalangeal joint. Six women and five men with an average age 51.9 years (46 to 58 years) and average postoperative follow-up of 3.73 years (3-4 years); were classified through the Kravitz system and evaluated by the American Orthopaedic Foot and Ankle Society (AOFAS) scales for hállux, Visual Analogical Scale (VAS) – analog functional pain - and range of motion in the first metatarsal joint in preoperative, postoperative after six months and present post-operative.

RESULTS: The results show significant improvement of the three analyzed parameters, both for overall analysis and for pre and post-operative comparisons individually. The comparative analysis of each variable in the six months and the current postoperative periods do not show statistically significant differences, indicating maintenance of parameters during this interval.

CONCLUSION: hemiarthroplasty of first metatarsophalangeal joint is a reproducible and safe option for the surgical treatment of hállux rigidus II and III, with significant improvement of the evaluated parameters for the studied population. Level of Evidence IV, Case Series.

Keywords: Hállux rigidus. Osteoarthrosis. Hemiarthroplasty.

INTRODUCTION

The osteoarthrosis of the first, called Hállux Rigidus (HR), is a progressive degenerative disease of the articular cartilage, characterized by limitation of the arch of articular movement, mainly the extension (dorsiflexion), associated to pain, formation of osteophytes and functional limitation.

It represents the most common form of osteoarthrosis of the foot and ankle, with annual prevalence of 2-10%,^1,2 predominance in females in the ratio, 1:1.6^3-10 and peak of incidence in the population after 50 years old.¹¹

In addition to the local trauma, inflammatory and metabolic diseases; biomechanical and anatomical factors that rise the mechanical overload in the first metatarsal-phalangeal articulation play a role in the physiopathogeny of HR.

The most adequate scientific correlations etiological with evidence are:^12,13

• Presence of the first long metatarsus

• Presence of the first elevated metatarsus

• Presence of hypermobility of the first ray

• Presence of interphalangeal hállux valgus

The painful symptoms and alteration of articular mechanics cause the transfer of the load to the lateral edge of the foot,^14,15 and to external rotation of the hip of the affected member during the balance phase of the walk. These alteration in the march pattern modify the forces that normally act in the foot and result in metatarsalgia of the lateral rays.^14,15

The Kravitz¹⁶ Classification System used:

Stage I - Functional limitation, without radiographic alterations;

Stage II - Initial articular adaptation, with dorsal osteophytes;

Stage III - Established osteoarthrosis;

Stage VI - Ankylosis, articular fusion.

The non-surgical treatment includes local cryotherapy, use of oral non hormonal anti-inflammatory drugs, intra-articular infiltration with corticosteroids and chondroprotectives, modification of the characteristics of footwear and physiotherapy. Upon failure of conservative treatment, surgical options are discussed in the literature.^3-10,17-19 (Table 1)

Kravitz's stages II and III generate greater controversy in the literature regarding the type of the indicated surgical treatment.^3,6-10,18,19

Currently, the standard surgical treatment in advanced cases is still metatarsal-phalangeal arthrodesis Comparative studies show that the articular fusion present a higher patient satisfaction rate when compared to arthroplasty.^{9, 20} However, the loss of mobility is not well tolerated by young adult active patients and complications of this procedure include: non-consolidation - 10% of cases, malposition of the proximal phalange, limitation of sports activities and increased stress in the lateral rays.^21,22 Therefore, it becomes necessary to investigate procedures for maintaining joint mobility; restitution of the normal walking pattern keeping the "reel" mechanism of the plantar fascia, assisting impulse and reducing the impact during deambulation.²³ Arthroplasty of the first metatarsophalangeal allows improvement of painful symptoms and restitution of joint mobility.^24-27

This surgical procedure can be classified into partial arthroplasty (replacement of the articular surfaces, base of the proximal phalange and the first metatarsal head) and total arthroplasty (replacement of both articular surfaces).²⁸ A systematic review of the literature shows the implants available for arthroplasty of the first metatarsophalangeal divided into four generations:¹⁹

1st generation - silicone implants, models for partial and total arthroplasty;

2nd generation - better quality silicone implants, for partial and total arthroplasty;

3rd generation - metallic prosthesis designed for partial and total arthroplasty, with "press-fit" type clamping system;

4th generation - metallic prosthetic designed for partial and total arthroplasty with medullar threaded rod fixing system.

An important advantage of partial arthroplasty is to preserve the bone, which allows, when necessary, carrying out rescue arthrodesis without subsequent bone graft. The prosthetic replacement of the first metatarsal head, were first used in 2005, with cobalt chrome implant in the articular surface, and titanium intramedullary rod (Arthrosurface HemiCAP). The system allows anatomic reconstruction of the articular surface of the metatarsal head, joint decompression, preservation of the extensor mechanism of the first ray and range of motion gain; it also allows the association with osteotomies of the proximal phalange, and thus, the correction of large hállux deformities. The published results of articular replacement of the first metatarsophalangeal joint with short-term follow-up are promising; however the procedure is under investigation and improvement of the employed materials and technique. The results in the literature motivate the prospective analysis of the experiments of the Foot and Ankle group with the surgical technique.

OBJECTIVE

Compare the pre-and postoperative findings visual of the Visual Analog Pain Scale (VAS), the Functional Scale of the American Orthopedics Foot and Ankle Society (AOFAS) for Hállux, and range of motion for patients with Hállux Rigidus grade II and III submitted to partial joint replacement with Arthrosurface-HemiCAP^® implant.

MATERIALS AND METHODS

After approval from the Scientific Committee and the Ethics Committee of the University, we selected 11 patients for treatment of Hállux Rigidus through partial arthroplasty of the first metatarsophalangeal with the Arthrosurface-HemiCAP^® technique from June 2008 to May 2009. All selected patients were diagnosed with Hállux Rigidus stage II or III, with no history of rheumatic diseases, metabolic diseases, foot infection or sequelae from fracture of the first metatarsus or proximal phalange of the hállux.

Excluding Criteria:

• Rheumatic diseases;

• Autoimmune diseases;

• Diabetes Mellitus;

• Liver and kidney diseases;

• Loss of tracking.

All patients were initially treated with appropriate footwear orientation and stretching of the triceps surae muscles for six months without symptomatic improvement.

The surgical procedure was performed by two surgeons specialize in foot and ankle through the dorsal access way preserving the insertion of the extensor mechanism of the hállux. The protocol of postoperative follow-up regarding the surgical dressing type, load and progression of motor rehabilitation is consistent with that standard by the Foot and Ankle Group of our institution. (Annex 1)

Selected patients underwent assessment following the steps listed below, in the preoperative, six months postoperative and current status:

1. Pain Scale VAS²⁹

2. American Orthopedics Foot and Ankle Society (AOFAS) Functional scale for hálux³⁰

3. Motion Range (MR) clinically measured with a goniometer. The data harvesting protocol is described in Annex 2.

Statistical analysis of the results.

The results analysis of the AOFAS hállux scale, VAS and range of motion for the first metatarsophalangeal joint during the measurements intervals, considered dependent variables and not-normally distributed, was performed using the Friedman test for nonparametric findings with significance values of p <0.05.

RESULTS

Table 2 shows age, tracking time (in years), values of AOFAS Hállux scale VAS pain scale -and range of motion (in degrees) of the first metatarsophalangeal joint (in degrees) in the measurement intervals.

Table 3 shows the descriptive analysis of the collected data. Table 4 presents the results of statistical analysis using Friedman test and Dunn's multiple comparisons, considering p <0.05 as statistically significant.

The results show significant improvement of the three parameters evaluated in this study, both for global analysis for comparisons as well as to pre-and postoperative isolated comparisons. A comparative analysis of each variable in postoperative periods of six months and current - three to four years after surgery - show no statistically significant difference, indicating the maintenance of parameters during this interval.

Figures 1 and 2 show the post-operative lateral and front X-ray profile of patient number six.

DISCUSSION

The hállux osteoarthritis is the most common form of degenera-tive joint disease of the foot and ankle, with annual prevalence of 2-10%^1,2 in the population above 50 years with predominance in the female gender.^3-10

Upon failure of non-surgical treatment, there are several options of surgical procedures discussed in the literature.

The optimal surgical treatment for patients with a Hállux Rigidus diagnosis is that which allows improvement of painful symptoms, restores the normal motion arc and joint alignment, keeps the length of the first ray and allows return to normal function of the foot and march. The metatarsophalangeal joint arthroplasty procedure is designed to meet these factors.

Most discussion in the literature is regarding the replacement or joint fusion for the treatment of stages II and III of the Kravitz classification system. Comparative studies have found greater satisfaction of patients undergoing arthrodesis compared with hállux arthroplasty.^{16, 23} The first metatarsophalangeal arthrodesis is a procedure that leads to effective pain relief and restores the patient's function.⁷ However, due to loss of mobility, it may not be tolerated by most active patients, particularly young one, besides presenting complication rates up to 10%.^26,27 Raikin et al.⁹ showed hemiarthroplasty ("metallic" Bio Pro) and arthrodesis with clinically similar results; they identified that arthrodesis postoporative evolution is more predictable in relienving symptoms and that most failures due to the choice of arthroplasty occur in the first two years postoperatively. Konkel et al.³¹ describe the successful use of hemiarthroplasty ("Futura Hemi-Great Toe"), with minimal radioluscency at the base of the implant during the radiographic follow-up, and lack of material failures in a mean follow-up period of eight years. In our series we did not identify flaws in arthroplasties during an average of 3.72 years.

Hasselman e Shields³² describe the use of metallic implant to cover the first metatarsal head (HemiCAP), performed with minimal bone resection, without changing the joint gleno-sesamoid articulation or interfere with the balance of the flexor and hállux extensor mechanisms, keeping the plate plant intact. The follow-up period of patients was 20 months, with an average gain range of motion of 42 degrees and average postoperative AOFAS score of 82.1 points.

In this series, the surgical technique allowed maintenance of the sesamoid joint with the first metatarsal head as well as the extensor and flexor hállux balance mechanisms, the average gain in MR was found to be 16.3 degrees and postoperative AOFAS average score observed was 77.27 points.

Sorbie e Saunders¹⁰ designed a prospective study with use of cemented hemiarthroplasty and observed improvement in the AOFAS score from 57 to 88 points, with follow-up ranging from 34-72 months, concluding that hemiarthroplasty improves pain symptoms, joint motion, bending force and joint alignment. The authors found no signs of osteolysis or loosening of the prosthesis. These data corroborate the results observed in the present series.

Cook et al.¹⁹ reported in a meta-analysis that evaluated arthroplasties of the first metatarsophalangeal, patient satisfaction from 85.7% to 94.5%, with an average follow up period of 61.48 months. The significant improvement of the three parameters evaluated in this study are similar to those published by Cook et al.¹⁹

Carpenter et al.³³ found similar results, in the medium-term, by replacing the head of the first methatarsal ("HemiCAP"), and for arthrodesis on the treatment of Hállux Rigidus, with a mean follow up period of 27 months - 89.31 AOFAS score for HemiCAP against 83.8 for artrodese.⁹

Despite little experience accumulated by our group that designed this study, analysis of clinical outcomes, with follow-up longer than three years, may contribute to the knowledge of the technique in our country and motivate prospective comparative and randomized trials.

CONCLUSION

The hemiarthroplasty of the 1^st metatarsophalangeal is a reproducible and safe option for the surgical treatment of Hállux Rigidus II and III, with significant improvement in articular range of motion, functional AOFAS scale and decreased pain by VAS score for the population studied.

REFERENCES

• 1. Feltham GT, Hanks SE, Marcus RE. Age-based outcomes of cheilectomy for the treatment of hállux rígidus Foot Ankle Int. 2001;22(3):1927.
• 2. Lau JT, Daniels TR. Outcomes following cheilectomy and interpositional arthroplasty in hállux rígidus Foot Ankle Int. 2001;22(6):46270.
• 3. Coughlin M. Hállux rígidus Grading and long-term results of operative treatment. J Bone Joint Surg Am. 2003;85(11):2072-88.
• 4. Hattrup SJ, Johnson KA. Subjective results of hállux rígidus following treatment with cheilectomy. Clin Orthop Relat Res. 1988;(226):18291.
• 5. Kilmartin TE. Phalangeal osteotomy versus first metatarsal decompression osteotomy for the surgical treatment of hállux rígidus: a prospective study of age-matched and condition-matched patients. J Foot Ankle Surg. 2005;44(1):212.
• 6. Brodsky JW, Passmore RN, Pollo FE, Shabat S. Functional outcome of arthrodesis of the first metatarsophalangeal joint using parallel screw fixation. Foot Ankle Int. 2005;26(2):1406.
• 7. Taranow WS, Moutsatson MJ, Cooper JM. Contemporary approaches to stage II and III hállux rígidus: the role of metallic hemiarthroplasty of the proximal phalanx. Foot Ankle Clin. 2005;10(4):71328.
• 8. Kennedy JG, Chow FY, Dines J, Gardner M, Bohne WH. Outcomes after interposition arthroplasty for treatment of hállux rígidus Clin Orthop Relat Res. 2006;445:2105.
• 9. Raikin SM, Ahmad J, Pour AE, Abidi N. Comparison of arthrodesis and metallic hemiarthroplasty of the hallux metatarsophalangeal joint. J Bone Joint Surg Am. 2007;89(9):197985.
• 10. Sorbie C, Saunders GA. Hemiarthroplasty in the treatment of hállux rígidus Foot Ankle Int. 2008;29(3):27381.
• 11. Carpenter B, Smith J, Motley T, Garrett A. Surgical treatment of hállux rígidus using a metatarsal head resurfacing implant: mid-term follow-up. J Foot Ankle Surg. 2010;49(4):3215.
• 12. Ettl V, Radke S, Gaertner M, Walther M. Arthrodesis in the treatment of hállux rígidus Int Orthop. 2003;27(6):3825.
• 13. Cracchiolo AA, Weltmer JB, Lian GG, Dalseth TT, Dorey FF. Arthroplasty of the first metatarsophalangeal joint with a double-stem silicone implant. Results in patients who have degenerative joint disease failure of previous operations, or rheumatoid arthritis. J Bone Joint Surg Am. 1992;74(4):55263.
• 14. DeFrino PF, Brodsky JW, Pollo FE, Crenshaw SJ, Beischer AD. First metatarsophalangeal arthrodesis: a clinical, pedobarographic and gait analysis study. Foot Ankle Int. 2002;23(6):496502.
• 15. Van Gheluwe B, Dananberg HJ, Hagman F, Vanstaen K. Effects of hallux limitus on plantar foot pressure and foot kinematics during walking. J Am Podiatr Med Assoc. 2006;96(5):42836.
• 16. Kravitz SR, LaPorta GA, Lawton JH. KLL progressive staging classification of hallux limitus and hállux rígidus Lower Extrem.1994;1(1):5566.
• 17. Moberg E. A simple operation for hállux rígidus Clin Orthop Relat Res. 1979;(142):556.
• 18. Yee G, Lau J. Current concepts review: hállux rígidus Foot Ankle Int. 2008;29(6):63746.
• 19. Cook E, Cook J, Rosenblum B, Landsman A, Giurini J, Basile P. Meta-analysis of first metatarsophalangeal joint implant arthroplasty. J Foot Ankle Surg. 2009;48(2):180190.
• 20. Gibson JN, Thomson CE. Arthrodesis or total replacement arthroplasty for hállux rígidus: a randomized controlled trial. Foot Ankle Int. 2005;26(9):680-90.
• 21. Coughlin MJ, Abdo RV. Arthrodesis of the first metatarsophalangeal joint with Vitallium plate fixation. Foot Ankle Int. 1994;15(1):1828.
• 22. Coughlin MJ, Shurnas PS. Hállux rígidus: demographics, etiology, and radiographic assessment. Foot Ankle Int. 2003;24(10):73143.
• 23. Brewster M. Does total joint replacement or arthrodesis of the first metatarsophalangeal joint yield better functional results? A systematic review of the literature. J Foot Ankle Surg. 2010;49(6):54652.
• 24. Stauffer RN. Salvage of painful total ankle arthroplasty. Clin Orthop Relat Res. 1982;(170):1848.
• 25. Kotnis R, Pasapula C, Anwar F, Cooke PH, Sharp RJ. The management of failed ankle replacement. J Bone Joint Surg Br. 2006; 88(8):103947.
• 26. Hopgood P, Kumar R, Wood PLR. Ankle arthrodesis for failed total ankle replacement. J Bone Joint Surg Br. 2006;88(8):10328.
• 27. Raikin SM, Rampuri V. An approach to the failed ankle arthrodesis. Foot Ankle Clin. 2008;13(3):40116.
• 28. Swanson AB, Lumsden RM, Swanson GD. Silicone implant arthroplasty of the great toe. A review of single stem and flexible hinge implants. Clin Orthop Relat Res. 1979;(142):3043.
• 29. Richter M, Zech S, Geerling J, Frink M. A new foot and ankle outcome score: Questionnaire based, subjective, Visual-Analogue-Scale, validated and computerized. Foot Ankle. 2006;12;1919.
• 30. Baumhauer JF, Nawoczenski DA, DiGiovanni BF, Wilding GE. Reliability and validity of the American Orthopaedic Foot and Ankle Society Clinical Rating Scale: a pilot study for the hallux and lesser toes. Foot Ankle Int. 2006;27(12):10149.
• 31. Konkel KF, Menger AG, Retzlaff SA. Midterm results of Futura hemi-great toe implants. Foot Ankle Int. 2008;29(8):831-7.
• 32. Hasselman CT, Shields N. Resurfacing of the first metatarsal head in the treatment of hállux rígidus Techn Foot Ankle Surg. 2008;7(1):3140.
• 33. Carpenter B, Smith J, Motley T, Garrett A. Surgical treatment of hállux rígidus using a metatarsal head resurfacing implant: mid-term follow-up. J Foot Ankle Surg. 2010;49(4):3215.

Publication Dates

• Publication in this collection
  14 June 2013
• Date of issue
  Apr 2013

History

• Received
  10 Aug 2012
• Accepted
  12 Sept 2012